Impairment Risk for Fixed Assets and Goodwill
First written in FY2016. 17 of 33 entries say "Materialised", first in FY2017-Q1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026WorsenedAnnual report
「The impairment loss totaled ¥21.913 billion, including ¥16.542 billion on investments accounted for under the equity method.」
The impairment loss increased from ¥18.5 billion in the previous fiscal year to ¥21.9 billion. The company recognized ¥7.898 billion in impairment related to the decision to transfer its SSMC interest and ¥6.83 billion in impairment of its investment in 日本エム・ディ・エム, among other items. - FY2026-H1WorsenedAnnual report
「Impairment loss 12,457 During the interim consolidated accounting period, the company recognized an impairment loss in connection with its decision to transfer its interest in Shanghai Sinopec Mitsui Chemicals Co., Ltd., an equity-method investee.」
The impairment loss increased from ¥5.622 billion in the interim period of the previous year to ¥12.457 billion. An impairment loss on the investment related to the decision to transfer the SSMC interest was also recognized. - FY2025-H1MitigatedAnnual report
「Impairment loss 5,622」
The impairment loss for the interim consolidated accounting period was ¥5.622 billion, down from ¥12.436 billion in the interim period of the previous year. However, impairment losses continue to be recognized. - FY2024-Q3WorsenedAnnual report
「Impairment loss 14,202」
The impairment loss for the cumulative consolidated period of the current third quarter was ¥14.202 billion, up from ¥3.953 billion in the same period of the previous year. An impairment loss was recognized in the process of classifying MCTI's PS business and other operations as held for sale. - FY2024-Q2WorsenedAnnual report
「Impairment loss 12,436」
The impairment loss for the cumulative period of the current second quarter was ¥12.436 billion, up from ¥3.784 billion in the same period of the previous year. An impairment loss was recognized in the process of classifying MCTI's PS business and other operations as held for sale. - FY2024-Q1WorsenedAnnual report
「Impairment loss 9,178」
The impairment loss for the cumulative consolidated period of the current first quarter was ¥9.178 billion, a substantial increase from ¥1.642 billion in the same period of the previous year. An impairment loss was recognized in the process of classifying MCTI's PS business and other operations as held for sale. - FY2023-Q3WorsenedAnnual report
「Impairment loss 3,953」
The impairment loss for the cumulative consolidated period of the current third quarter was ¥3.953 billion, a substantial increase from ¥251 million in the same period of the previous year. The impairment risk for fixed assets and goodwill continues to be reflected in results. - FY2023-Q2WorsenedAnnual report
「Impairment loss 3,784」
The impairment loss for the cumulative period of the current second quarter was ¥3.784 billion, up from ¥120 million in the same period of the previous year. - FY2023-Q1MaterialisedAnnual report
「Impairment loss 1,642」
The company recognized an impairment loss of ¥1.642 billion in the cumulative consolidated period for the current first quarter, and impairment of fixed assets and goodwill was reflected in results. - FY2022WorsenedAnnual report
「Total impairment loss 16,183」
The impairment loss increased from ¥8.05 billion in the previous fiscal year to ¥16.183 billion. The company recognized ¥13.267 billion on the Omuta manufacturing facilities and other assets in the Basic Materials segment, and ¥1.507 billion on manufacturing facilities for mobility products in the Netherlands. - FY2022-Q3MaterialisedAnnual report
「Impairment loss 251」
The company recognized an impairment loss of ¥251 million in the cumulative period for the current third quarter, up from ¥53 million in the same period of the previous year. The impairment risk for fixed assets and goodwill continues to be reflected in results. - FY2022-Q2MaterialisedAnnual report
「Impairment loss 120」
The company recognized an impairment loss of ¥120 million in the cumulative period for the current second quarter, up from ¥41 million in the same period of the previous year. The impairment risk for fixed assets and goodwill continues to be reflected in results. - FY2021MaterialisedAnnual report
「During the fiscal year, the carrying amounts of goodwill and intangible assets related to 株式会社アークグループ were reduced to their recoverable amounts because profitability deteriorated as the number of development projects declined due to weak earnings at manufacturing companies, particularly in the automotive industry.」
Impairment of goodwill and intangible assets related to アークグループ, including ¥4.868 billion, occurred, bringing the fiscal-year impairment loss to ¥8.05 billion. - FY2021-Q3MaterialisedAnnual report
「Impairment loss 53」
The company recognized an impairment loss of ¥53 million in the cumulative consolidated period for the current third quarter, and impairment of fixed assets and goodwill continues to be reflected in results, as in the previous quarter. However, this was down from ¥1.211 billion in the same period of the previous year. - FY2021-Q2MaterialisedAnnual report
「Impairment loss 41」
The company recognized an impairment loss of ¥41 million in the cumulative consolidated period for the current second quarter, and the impairment loss, which had not been recognized in the previous quarter, recurred. - FY2021-Q1MitigatedAnnual report
「Impairment loss —」
No impairment loss was recognized in the cumulative consolidated period for the current first quarter, and the impairment losses that had continued through the immediately preceding fiscal year did not occur during the current quarter. - FY2020MaterialisedAnnual report
「During the fiscal year, the group recognized an impairment loss of ¥2.5 billion, primarily on assets used in its businesses, across the group as a whole.」
Impair losses on fixed assets increased from ¥1.454 billion in the previous fiscal year to ¥2.508 billion, and the impairment risk continued to be reflected in results. - FY2020-Q3MaterialisedAnnual report
「Impairment loss 1,151」
The company recognized an impairment loss of ¥1.151 billion in the cumulative consolidated period for the current third quarter, and impairment of fixed assets and goodwill continues to be reflected in results. - FY2020-Q2MaterialisedAnnual report
「Impairment loss 673」
The company recognized an impairment loss of ¥673 million in the cumulative consolidated period for the current second quarter, and impairment of fixed assets and goodwill continues to be reflected in results. - FY2020-Q1MaterialisedAnnual report
「Impairment loss 603」
The company recognized an impairment loss of ¥603 million in the cumulative consolidated period for the current first quarter, and impairment of fixed assets and goodwill continues to be reflected in results. - FY2019MitigatedAnnual report
「Impairment loss 1,454」
Impair losses on fixed assets decreased from ¥15.012 billion in the previous fiscal year to ¥1.454 billion, but an impairment loss was also recognized in the current fiscal year. - FY2019-Q3MaterialisedAnnual report
「Impairment loss 918」
The company recognized an impairment loss of ¥918 million in the cumulative consolidated period for the current third quarter, and the impairment risk is now reflected in results. - FY2019-Q2MaterialisedAnnual report
「Impairment loss 660」
The company recognized an impairment loss of ¥660 million in the cumulative consolidated period for the current second quarter, changing the situation from the previous quarter, when no material impairment loss was deemed to have occurred. - FY2019-Q1MitigatedAnnual report
「This was not disclosed because no material impairment loss had been recognized and no event had occurred that would materially affect the amount of goodwill or other items.」
During the cumulative period for the first quarter, no material impairment loss or event that would materially affect goodwill or other items was recognized. - FY2018MaterialisedAnnual report
「In the consolidated fiscal year, the group recorded impairment losses of ¥15 billion as a result of impairment charges in the dental materials business and other operations.」
Against a backdrop of sluggish sales in Germany and delays in launching digital-related products, the group incurred total impairment losses of ¥15 billion, including ¥14.35 billion in goodwill and other assets in the dental materials business. - FY2018-Q3MitigatedAnnual report
「This was not disclosed because no material impairment loss had been recognized and no event had occurred that would materially affect the amount of goodwill or other items.」
It was stated that no material impairment loss had been recognized during the cumulative period for the third quarter, and no impairment loss was identified during that period. - FY2017MaterialisedAnnual report
「In the consolidated fiscal year, the group recorded impairment losses of ¥4.1 billion, primarily on assets used in the business, in connection with business structure improvements and other measures.」
The company recorded ¥4.1 billion in impairment losses on fixed assets during the fiscal year. - FY2017-Q3MaterialisedAnnual report
「Impairment loss ¥350 million」
The company also recorded an impairment loss of ¥350 million in the cumulative period for the third quarter, and impairment losses continued to occur. - FY2017-Q2MaterialisedAnnual report
「Impairment loss ¥344 million」
The company also recorded an impairment loss of ¥344 million in the cumulative period for the second quarter, and impairment losses continued to occur. - FY2017-Q1MaterialisedAnnual report
「Impairment loss ¥343 million」
The company also recorded an impairment loss of ¥343 million in the quarter, and impairment losses continued to occur. - FY2016First statedAnnual report
「In the consolidated fiscal year, the dental materials business acquired by the company in fiscal 2013 fell behind its initial profit plan, resulting in impairment of goodwill, among other factors. The group recorded impairment losses of ¥24.1 billion, primarily on assets used in the business.」
The impairment risk actually materialized during the fiscal year due to delays in the profit plan for the dental materials business, among other factors.